Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (france) - probenecid - oral tablet - 500mg

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

kaken pharmaceutical co., ltd. - probenecid - white to pale yellowish white tablet, diameter: 10.1mm

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - doxorubicin hydrochloride -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

daunorubicin -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - doxorubicin hydrochloride -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - doxorubicin hydrochloride -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - doxorubicin hydrochloride -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - lignocaine hydrochloride anhydrous -

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - doxorubicin hydrochloride 2 mg/ml;   - concentrate for injection - 2 mg/ml - active: doxorubicin hydrochloride 2 mg/ml   excipient: hydrochloric acid sodium chloride water for injection - doxorubicin has been used successfully to produce regression in neoplastic conditions, e.g. acute leukaemia, wilms' tumour, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, lymphomas of both hodgkin's and non-hodgkin's type, bronchogenic (lung) carcinoma, thyroid carcinoma, hepatomas and ovarian carcinoma etc. doxorubicin is also indicated in the primary management of nonmetastatic carcinoma of the bladder (tis, t1, t2) by intravesical administration.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

caduceus pharma ltd - cisplatin - concentrate for soln for inf - 1 mg/ml - platinum compounds